Dimensional Fund Advisors’s Crinetics Pharmaceuticals CRNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.04M | Buy |
175,257
+155,534
| +789% | +$4.47M | ﹤0.01% | 2518 |
|
|
2025
Q1 | $662K | Buy |
+19,723
| New | +$662K | ﹤0.01% | 2961 |
|
|
2024
Q4 | – | Sell |
-392,196
| Closed | -$20M | – | 3347 |
|
|
2024
Q3 | $20M | Sell |
392,196
-154,563
| -28% | -$7.9M | ﹤0.01% | 1998 |
|
|
2024
Q2 | $24.5M | Sell |
546,759
-94,043
| -15% | -$4.21M | 0.01% | 1867 |
|
|
2024
Q1 | $30M | Sell |
640,802
-19,119
| -3% | -$895K | 0.01% | 1776 |
|
|
2023
Q4 | $23.5M | Sell |
659,921
-84,895
| -11% | -$3.02M | 0.01% | 1905 |
|
|
2023
Q3 | $22.2M | Buy |
744,816
+225,707
| +43% | +$6.71M | 0.01% | 1867 |
|
|
2023
Q2 | $9.35M | Buy |
519,109
+69,504
| +15% | +$1.25M | ﹤0.01% | 2290 |
|
|
2023
Q1 | $7.22M | Sell |
449,605
-59,243
| -12% | -$951K | ﹤0.01% | 2355 |
|
|
2022
Q4 | $9.31K | Sell |
508,848
-27,222
| -5% | -$498 | ﹤0.01% | 2234 |
|
|
2022
Q3 | $10.5M | Sell |
536,070
-17,801
| -3% | -$350K | ﹤0.01% | 2135 |
|
|
2022
Q2 | $10.3M | Buy |
553,871
+64,514
| +13% | +$1.2M | ﹤0.01% | 2176 |
|
|
2022
Q1 | $10.7M | Buy |
489,357
+143,913
| +42% | +$3.16M | ﹤0.01% | 2266 |
|
|
2021
Q4 | $9.81M | Buy |
345,444
+34,100
| +11% | +$969K | ﹤0.01% | 2317 |
|
|
2021
Q3 | $6.55M | Buy |
311,344
+126,051
| +68% | +$2.65M | ﹤0.01% | 2497 |
|
|
2021
Q2 | $3.49M | Buy |
185,293
+119,573
| +182% | +$2.25M | ﹤0.01% | 2710 |
|
|
2021
Q1 | $1M | Buy |
65,720
+41,825
| +175% | +$639K | ﹤0.01% | 3017 |
|
|
2020
Q4 | $337K | Buy |
+23,895
| New | +$337K | ﹤0.01% | 3159 |
|